GSK plc
GSK
$37.56
$0.411.10%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 4.96B | 5.79B | 5.42B | 4.31B | 3.77B |
Total Receivables | 10.55B | 9.69B | 8.23B | 10.54B | 9.83B |
Inventory | 8.32B | 7.75B | 7.10B | 7.93B | 7.40B |
Prepaid Expenses | -- | -- | 488.25M | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 390.46M | 127.91M | 46.32M | 403.43M | 181.99M |
Total Current Assets | 24.21B | 23.37B | 21.28B | 23.18B | 21.19B |
|
|||||
Total Current Assets | 24.21B | 23.37B | 21.28B | 23.18B | 21.19B |
Net Property, Plant & Equipment | 13.59B | 12.88B | 12.61B | 13.03B | 12.41B |
Long-term Investments | 9.23B | 8.95B | 8.74B | 8.95B | 8.80B |
Goodwill | 9.23B | 8.95B | 8.74B | 8.95B | 8.80B |
Total Other Intangibles | 21.07B | 21.01B | 19.42B | 20.12B | 19.55B |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 11.76B | 10.90B | 10.85B | 11.03B | 9.98B |
Total Assets | 81.19B | 78.43B | 74.44B | 77.80B | 73.38B |
|
|||||
Total Accounts Payable | 18.70B | 17.88B | 4.33B | 18.06B | 16.84B |
Total Accrued Expenses | -- | -- | 5.08B | -- | -- |
Short-term Debt | 376.76M | 275.20M | -- | 219.81M | 104.89M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.43B | 2.25B | 2.94B | 3.55B | 4.15B |
Total Finance Division Other Current Liabilities | 6.41B | 6.50B | 14.81B | 6.93B | 4.62B |
Total Other Current Liabilities | 6.41B | 6.50B | 14.81B | 6.93B | 4.62B |
Total Current Liabilities | 27.92B | 26.91B | 27.16B | 28.76B | 25.71B |
|
|||||
Total Current Liabilities | 27.92B | 26.91B | 27.16B | 28.76B | 25.71B |
Long-Term Debt | 20.97B | 21.28B | 17.16B | 17.75B | 17.16B |
Short-term Debt | 376.76M | 275.20M | -- | 219.81M | 104.89M |
Capital Leases | -- | -- | 1.17B | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 12.63B | 12.59B | 12.57B | 13.26B | 13.11B |
Total Liabilities | 61.52B | 60.79B | 58.06B | 59.77B | 55.98B |
|
|||||
Common Stock & APIC | 6.62B | 6.24B | 6.04B | 6.46B | 6.09B |
Retained Earnings | 12.05B | 10.73B | 10.98B | 10.97B | 10.85B |
Treasury Stock & Other | 1.59B | 1.31B | 103.91M | 1.34B | 1.22B |
Total Common Equity | 20.26B | 18.29B | 17.12B | 18.77B | 18.16B |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 20.26B | 18.29B | 17.12B | 18.77B | 18.16B |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -598.71M | -649.88M | -732.38M | -743.87M | -760.80M |
Total Equity | 19.67B | 17.64B | 16.38B | 18.03B | 17.40B |
|